The natural history of pityriasis rosea in black American children: how correct is the "classic" description?
To delineate the natural history of pityriasis rosea in black children and to compare our findings with those of the American, European, and African literature on pityriasis rosea. Textbook and journal article descriptions of pityriasis rosea usually offer information about the presentation and clinical course of this condition in white patients.



Prospective observational study.



The general pediatric clinic, adolescent clinic, and emergency department of Children's Hospital of Michigan, Detroit, from June 2003 through May 2005.



We followed up 50 black children with pityriasis rosea from the time of diagnosis through follow-up visits at 1, 2, and 4 weeks. Detailed observations were made and digital photographs taken at each visit.



Duration of illness and pigmentary sequelae.



Similarities with the medical literature were found regarding season of onset and prevalence of pruritus and of a herald patch. Our patients had more frequent facial involvement (30%) and more scalp lesions (8%) than usually described in white populations. One third had papular lesions. The disease resolved in nearly one half of patients within 2 weeks. Residual hyperpigmentation was seen in 48% of patients. Hypopigmentation developed in 29% of patients with purely papular or papulovesicular lesions.



Pityriasis rosea in black children differs in several ways from textbook descriptions. Physicians may use this information to better counsel patients about the course and potential sequelae of this condition.
Amer
Ahdi
A
The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Children's Hospital of Michigan, Detroit 48201, USA. aamer@med.wayne.edu
Fischer
Howard
H
Li
Xiaoming
X
D001741:Black or African American; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D002648:Child; D002669:Child Welfare / Q000208:ethnology*; D003937:Diagnosis, Differential; D005260:Female; D006776:Hospitals, Pediatric; D006801:Humans; D008297:Male; D008824:Michigan / Q000453:epidemiology; D017515:Pityriasis Rosea / Q000175:diagnosis* / Q000188:drug therapy / Q000208:ethnology*; D015995:Prevalence; D011446:Prospective Studies; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D017963:Azithromycin